- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Congress Must Act for Cannabis Patients! Pass Medical Cannabis Legislation NOW! Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2021 State of the States Medical Cannabis in America Cannabis and Cannabis Resin- Critical Review Preparation Document Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- News News
- Join Join
By Johnny Green for WeedNews
“After years of inexcusable delay, the DEA has finally taken a small step forward in the potential licensing of new cannabis cultivation facilities for scientific research. ASA has urged reform in this area for over a decade, and we hope that the DEA will move expeditiously now that the framework of a plan for license application review has finally been made public.” - Steph Sherer
According to a press release by the U.S. Department of Justice on Monday, the Drug Enforcement Administration has filed a notice in the Federal Register of its intention to promulgate regulations that govern the growing of cannabis for scientific and medical research under DEA registration. This announcement comes just days before a court deadline to respond to a lawsuit by researchers–including Americans for Safe Access’ (ASA) longtime supporter Dr. Sue Sisley–and mounting bipartisan pressure from Congressional lawmakers to move forward on the applications that the DEA began collecting three years ago from prospective growers.
It is not known exactly when the Department of Justice will move forward on the applications since the DEA must draft the new regulations and release them for public comment before they can be finalized. Once the final regulations have been promulgated, the DEA will be able to review and score the applications it received and issue licenses to successful applicants.
ASA and the medical cannabis community would welcome the addition of new, federally approved cannabis cultivation facilities. The government has been using only one facility, at the University of Mississippi, for the last 50 years to grow cannabis for federal research, and the quality of the cannabis produced there has been decried by researchers to whom it has been supplied. “After years of inexcusable delay, the DEA has finally taken a small step forward in the potential licensing of new cannabis cultivation facilities for scientific research,” said ASA Founder and President Steph Sherer. “ASA has urged reform in this area for over a decade, and we hope that the DEA will move expeditiously now that the framework of a plan for license application review has finally been made public.”